Eric Gilson Selected Research

Eric Gilson Research Topics

Disease

25	Neoplasms (Cancer) 06/2021 - 01/2004
9	Carcinogenesis 01/2019 - 01/2005
6	Chromosomal Instability (Chromosome Stability) 01/2018 - 05/2008
4	Melanoma (Melanoma, Malignant) 01/2021 - 08/2006
3	Genomic Instability 06/2010 - 01/2005
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 01/2020
2	Ataxia Telangiectasia (Louis Bar Syndrome) 02/2022 - 07/2016
2	Chromosome Aberrations (Chromosome Abnormalities) 09/2009 - 01/2005
1	Proteinuria 02/2024
1	AIDS-Associated Nephropathy (HIV-Associated Nephropathy) 02/2024
1	Chronic Renal Insufficiency 02/2022
1	Mental Disorders (Mental Disorder) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Rectal Neoplasms (Rectal Cancer) 01/2017
1	Nevus (Nevi) 01/2016
1	Circulating Neoplastic Cells 01/2016
1	Ovarian Neoplasms (Ovarian Cancer) 12/2015
1	Inflammation (Inflammations) 03/2015
1	Aneuploidy (Aneuploid) 12/2013
1	Hypersensitivity (Allergy) 03/2013
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 08/2012
1	Testicular Neoplasms (Testicular Cancer) 10/2009
1	Facioscapulohumeral Muscular Dystrophy 02/2009
1	Leukemia 02/2004

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 02/2024 - 09/2009
8	Telomerase (Telomerase Reverse Transcriptase)IBA 02/2024 - 01/2004
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2013
5	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2005
4	LigandsIBA 02/2015 - 11/2008
2	Phosphotransferases (Kinase)IBA 02/2022 - 02/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 03/2014
2	Shelterin ComplexIBA 03/2016 - 09/2010
2	ChromatinIBA 04/2011 - 09/2010
2	NucleoproteinsIBA 09/2010 - 06/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	N- (4- methoxybenzyl)- N'- (5- nitro- 1,3- thiazol- 2- yl)ureaIBA 06/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Sirtuin 3IBA 01/2020
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020
1	SilverIBA 01/2019
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2019
1	Schizosaccharomyces pombe ProteinsIBA 01/2018
1	Telomeric Repeat Binding Protein 2IBA 01/2017
1	Serine (L-Serine)FDA Link 07/2016
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2016
1	A-Form DNA (A-DNA)IBA 01/2016
1	cyclohexane- 1,2,4- tris(methylenesulfonate) (CTMS)IBA 01/2016
1	Matrix Metalloproteinases (MMPs)IBA 01/2016
1	Carboplatin (JM8)FDA LinkGeneric 12/2015
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 07/2015
1	Purinergic Receptors (Receptors, Purine)IBA 03/2015
1	CytokinesIBA 03/2015
1	Adenosine Triphosphate (ATP)IBA 03/2015
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 03/2015
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2014
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 03/2014
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 03/2014
1	CateninsIBA 04/2013
1	DNA-Binding Proteins (DNA Binding Protein)IBA 04/2013
1	permanganic acid (permanganate)IBA 03/2013
1	Potassium PermanganateIBA 03/2013
1	CytosineIBA 03/2013
1	DNA Transposable Elements (Element, IS)IBA 01/2012
1	ST 1481 (Gimatecan)IBA 04/2011
1	trioctyl phosphine oxide (TOPO)IBA 04/2011
1	Indicators and Reagents (Reagents)IBA 10/2009
1	Bromodeoxyuridine (BrdU)IBA 09/2009
1	LaminsIBA 02/2009
1	Phosphatidylinositols (Phosphatidylinositol)IBA 02/2009
1	Irinotecan (Camptosar)FDA LinkGeneric 11/2008
1	SaltsIBA 11/2008
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 05/2008
1	Telomere-Binding ProteinsIBA 08/2006
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2005
1	EnzymesIBA 01/2005

Therapy/Procedure

4	Therapeutics 02/2022 - 09/2009
3	Drug Therapy (Chemotherapy) 03/2015 - 11/2008